Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| OCG | Oriental Culture Ltd | $2.54 | -$6.16 | -70.81% | 4.4M | $184.7M | $1.09$19.29 |
| BBGI | Beasley Broadcast Group | $10.50 | -$6.19 | -37.09% | 2.4M | $30.1M | $3.67$26.37 |
| ASPC | A Spac III Acquisition Corp. | $11.19 | -$5.62 | -33.43% | 105.5K | $39.3M | $9.95$63.98 |
| ORCX | Tidal Trust II - Defiance Daily Target 2x Long Orcl ETF | $16.79 | -$6.68 | -28.47% | 13M | - | $9.05$60.53 |
| ORCU | Direxion Shares ETF Trust - Daily Orcl Bull 2x Etf | $18.01 | -$7.10 | -28.29% | 1.4M | - | $16.81$27.62 |
| SKIL | Skillsoft | $5.95 | -$1.76 | -22.83% | 502.2K | $67.2M | $4.65$34.43 |
| XOMA | XOMA | $26.78 | -$7.58 | -22.06% | 150.9K | $425.5M | $18.35$39.92 |
| OXM | Oxford Industries | $31.76 | -$8.69 | -21.48% | 1.3M | $601.4M | $30.57$89.86 |
| FBYD | Falcon's Beyond Global | $13.46 | -$3.47 | -20.50% | 72.7K | $630.6M | $3.62$29.02 |
| HODU | Direxion Shares ETF Trust - Direxion Daily Hood Bull 2x ETF | $27.79 | -$6.01 | -17.78% | 27.2K | - | $20.78$35.58 |
Related Articles
Featured Article
1 Brand-New Big Reason to Buy This Biotech Stock Right Now
Alex Carchidi|Oct 24, 2024
This stock currently has a good balance of risk and potential rewards.
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
Alex Carchidi|Oct 3, 2024
These two could become direct competitors relatively soon.
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
Alex Carchidi|Sep 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.
Advertisement
3 Luxury Stocks That Long-Term Investors Should Love
Michael Byrne|Dec 16, 2022
The luxury space is a good place for investors to be heading into next year.
Kick Your Feet Up with Shares of This Luxury Apparel Stock
Michael Byrne|Dec 15, 2022
Oxford Industries owns such popular brands as Tommy Bahama, Southern Tide, and Lily Pulitzer.
This Under-the-Radar Pharma Company Could Be a Bargain Hunter's Dream
Jeffrey Little|Oct 2, 2021
Pre-clinical successes lead to exclusive licensing agreements for iBio.
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
Alex Carchidi|Jan 1, 2021
Innovation paid off big for investors.
Is It Too Late to Buy iBio Stock?
Zhiyuan Sun|Oct 29, 2020
The time to make money by investing in iBio is over. Here's why that's good news.
3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
Keith Speights|Oct 8, 2020
Here's what it would take.
3 Compelling Biotech Stocks to Consider Buying While They're Hot on Robinhood
Alex Carchidi|Sep 20, 2020
These companies are certainly risky, but they might have what it takes to deliver serious growth for investors.
